The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan
Year: 2005
Type: article
Source: Anti-Cancer Drugs
Authors: Ada Henrike Braun, Katrin Stark, Olaf Dirsch, Ralf Axel Hilger, Siegfried Seeber, Udo Vanhoefer
Institution: University of Duisburg-Essen
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2016386446